NCT04527289View on ClinicalTrials.gov

Impact of Amantadine on Traumatic Brain Injury

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2020

Primary Completion Date

October 1, 2021

Study Completion Date

October 30, 2021

Conditions
Trauma, Brain
Interventions
DRUG

Amantadine (100mg) as add on therapy.

Amantadine (100mg) as add on therapy to the management regimen of traumatic brain injury - 100mg twice daily Oral or feeding tube

DRUG

Placebo

patients will be managed with placebo as add on to the standard regimen.

Trial Locations (1)

31527

Tanta University Hospital, Tanta

All Listed Sponsors
lead

Damanhour University

OTHER

NCT04527289 - Impact of Amantadine on Traumatic Brain Injury | Biotech Hunter | Biotech Hunter